Search by Drug Name or NDC
NDC 71610-0030-30 Divalproex Sodium 250 mg/1 Details
Divalproex Sodium 250 mg/1
Divalproex Sodium is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is DIVALPROEX SODIUM.
Product Information
| NDC | 71610-0030 |
|---|---|
| Product ID | 71610-030_fd96336e-88f7-4dbe-95c3-6af522e39ff8 |
| Associated GPIs | 72500010107520 |
| GCN Sequence Number | 051469 |
| GCN Sequence Number Description | divalproex sodium TAB ER 24H 250 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 18754 |
| HICL Sequence Number | 001884 |
| HICL Sequence Number Description | DIVALPROEX SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Divalproex Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | divalproex sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIVALPROEX SODIUM |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077567 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71610-0030-30 (71610003030)
| NDC Package Code | 71610-030-30 |
|---|---|
| Billing NDC | 71610003030 |
| Package | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-030-30) |
| Marketing Start Date | 2018-11-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |